RxDoctor Payments Data

Faizullah Syed

Internal Medicine · Sheffield, ALNPI 1902845589

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,938 of the $3,221 with a category attached, or 60.2%. Eli Lilly accounts for 79.9% of it on its own, with 19 other manufacturers making up the rest.

$3,221in general payments, 2019–2025

Across 94 payments — averaging $34.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$3K
  • Novo Nordisk$134
  • Indivior Inc.$97
  • AbbVie$63
  • Johnson & Johnson$50
  • GSK$45
  • plus $259 from 14 others
$396,973in research payments, 2019–2025

Across 35 payments — averaging $11,342 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$185K
  • Sanofi US Services Inc.$104K
  • AstraZeneca$70K
  • Astrazeneca AB$38K
  • Janssen Research & Development, LLC$12

What the payments were for

  • Travel & lodging$1,93860%
  • Food & beverage$1,28340%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,221 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama

Other internal medicine in Sheffield

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →